SEC approves BlackRock’s spot bitcoin ETF options listing

(Reuters) -The U.S. Securities and Exchange Commission has approved listing and trading of options for asset manager BlackRock’s spot bitcoin exchange-traded fund on the Nasdaq. Options trading for BlackRock’s fund iShares Bitcoin Trust has been approved with ticker symbol “IBIT”, the regulator said in a notice on Friday. The index options – listed derivatives offering…

Read More

China ex central bank adviser proposes $1.4 trillion in stimulus measures

HONG KONG (Reuters) – China could issue ultra-long-term treasury bonds within two years to generate at least 10 trillion yuan ($1.4 trillion) worth of stimulus to the economy, a former central bank adviser said on Saturday, according to state media. China should introduce a basket of measures, focusing on enhancing social protections, buying unsold apartments…

Read More

Swiss regulator investigating Credit Suisse’s final months, report says

ZURICH (Reuters) – Swiss financial market regulator FINMA ordered an audit into Credit Suisse’s handling of events leading to its demise in 2023, when the bank was acquired by its longtime rival UBS, Swiss newspaper SonntagsZeitung reported on Sunday. According to the paper, FINMA is looking at the 15 months prior to the state-orchestrated merger…

Read More

Exclusive-Iran withheld launchers for missiles sent to Russia, sources say

By Jonathan Landay, Phil Stewart and Anthony Deutsch WASHINGTON (Reuters) – Iran did not include mobile launchers with the close-range ballistic missiles that Washington last week accused Tehran of delivering to Russia for use against Ukraine, according to three sources with knowledge of the matter. The sources – a European diplomat, a European intelligence official…

Read More

Novo Nordisk shares drop nearly 5% on disappointing obesity pill data

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk’s shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker’s experimental obesity pill monlunabant came in below market expectations. The company announced headline results from its trial of monlunabant, an experimental drug it acquired as part of its…

Read More

Fed’s relaxed bank-capital plan faces FDIC pushback, Bloomberg News reports

(Reuters) – The U.S. Federal Reserve’s watered-down version of a landmark bank capital proposal is facing resistance from the Federal Deposit Insurance Corporation, a top banking regulator, Bloomberg News reported on Friday. At least three of five FDIC directors oppose the latest overhaul, the report said, citing people familiar with their thinking. The report points…

Read More